Pharma Pulse 10/28/24: Identifying Illicit Actors vs Compound Pharmacies, Cancer Disparities in Rural Areas & more

Identifying Illicit Actors vs Compound Pharmacies

Scott Brunner, CEO of the Alliance for Pharmacy Compounding, explains how to identify a compound pharmacy versus and illicit actor.

Cancer Disparities in Rural Areas: The Impact of Social Determinants of Health and Access Challenges

In a Pharmacy Times interview, Nathan Vanderford, PhD, MBA, Associate Professor of Toxicology and Cancer Biology in the College of Medicine at the University of Kentucky, will discuss cancer disparities and social determinants of health experienced by patients with cancer in rural communities, using his home state of Kentucky as a case study. He sheds light on the various factors, such as limited institutions and resources, that prevent health care professionals from providing the care that many patients need.

Government ‘Guardrails’ for A.I. Tools

A national security memorandum detailed how agencies should streamline operations with artificial intelligence safely.

President Biden has released a series of documents that grapple with the challenges of using A.I. tools to speed up government operations.

LabGenomics USA Completes Acquisition of IMD CLIA Labs

LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition strengthens LabGenomics’ strategic development and expands its diagnostic services nationwide, particularly in molecular technology.

James Watson on LinkedIn

In the latest episode of the Pharmaceutical Commerce Magazine podcast, Intelliguard® Chief Product Officer, Rob Sobie, shares invaluable insights into the current landscape of the pharmaceutical supply chain.

🔍 Key Challenges Facing Hospitals: Rob discusses the pressing issues hospitals are grappling with today, from inventory management to ensuring patient safety.

🚨 The Failing Drug Supply Chain: He highlights his concerns about the drug supply chain, emphasizing areas that need urgent attention to enhance reliability and efficiency.

💡 RFID Technology Successes: Rob also shines a light on the successful implementation of RFID technology, illustrating how it's revolutionizing tracking and inventory processes within healthcare facilities.

📜 Drug Supply Chain Security Act Overview: Rob provides a high-level overview of the Drug Supply Chain Security Act and shares his thoughts on the recent FDA exemptions, offering a critical perspective on their implications for the industry.

Listen to the full podcast here: https://hubs.ly/Q02VVFGZ0

#MedicationManagement #RFID #MedicationSupplyChain

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs